ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 269721 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 269721; 2) Community: the network communities that were significantly associated with the response to NSC 269721; 3) Molecule: the relationships between components within communities and NSC 269721; 4) MDR: the compounds that were significantly associated with the NSC 269721.

NSC Compound Enrichment Correlation
NSC 666783 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(4-methoxy- phenyl)amino]methyl]-5-methyl-, 3/5 methanol 0.00356914129105573 0.37878076
NSC 44580 9H-Purin-2-amine, 6-[[(2-chlorophenyl)methyl]thio]-9-propyl- 0.00356914129105574 0.488705
NSC 683557 Camptothecin Derivative 0.00356914129105574 0.59844944
NSC 694483 Null 0.00356914129105574 0.48502368
NSC 732112 6-(O-ethyl-2?-diethylamino)-7-(p-methoxycinnamoyl)-3-methyl- benzofuran-2-carboxylic acid ethyl ester hydrochloride 0.00356914129105574 0.16086373
NSC 77830 Cycloguanil Pamoate (USAN) 0.00356914129105574 0.47165702
NSC 123111 Mitomycin derivative T 53 0.00396220821750022 0.48891388
NSC 153353 L-Alanosine 0.00396220821750022 0.27262132
NSC 26692 4,5-bis(4-Methoxyphenyl)-1H-imidazol-2(5H)-one 0.00396220821750022 0.18312509
NSC 622700 Methanaminium, (2-oxo-1,3-cyclohexanediyl)bis(methyl)bis [N,N,N-trimethyl-, diiodide 0.00396220821750027 -0.0056720693
Total:61  Current:5    [First] [Prev] [Next] [Last]